Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension

Respiratory Medicine

Volumn 103, Issue 11, 2009, Pages 1663-1671

  Andersen, C U ^a   Markvardsen, L H ^a   Hilberg, O ^b   Simonsen, U ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Angiotensin II; Apelin; Hypoxia; Plasma markers; Pulmonary hypertension; Pulmonary vessels

Indexed keywords

ANGIOTENSIN II; APELIN; APELIN RECEPTOR; BIOLOGICAL MARKER; ENDOTHELIN 1;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; LUNG; LUNG ARTERY; LUNG PARENCHYMA; MALE; MEASUREMENT; MYOGRAPHY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASOCONSTRICTION;

ANIMALS; ANOXIA; CARRIER PROTEINS; HEART VENTRICLES; HYPERTENSION, PULMONARY; LUNG; MALE; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 70349496049     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.05.011     Document Type: Article

References (30)

1. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 (1987) 216-223
2. Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 (2002) 780-788
3. Charloux A., Chaouat A., Brandenberger G., et al. Spontaneous short-term variations of circulating endothelin-1 in pulmonary hypertension. Transl Res 151 (2008) 119-121
4. Aubert J.D. Biochemical markers in the management of pulmonary hypertension. Swiss Med Wkly 135 (2005) 43-49
5. Kereveur A., Callebert J., Humbert M., et al. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 20 (2000) 2233-2239
6. Lederer D.J., Horn E.M., Rosenzweig E.B., et al. Plasma serotonin levels are normal in pulmonary arterial hypertension. Pulm Pharmacol Ther 21 (2008) 112-114
7. Nagaya N., Uematsu M., Satoh T., et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 160 (1999) 487-492
8. Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 202-208
9. Mair J. Biochemistry of B-type natriuretic peptide - where are we now?. Clin Chem Lab Med 46 (2008) 1507-1514
10. Goetze J.P., Rehfeld J.F., Carlsen J., et al. Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept 133 (2006) 134-138
11. Kawamata Y., Habata Y., Fukusumi S., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538 (2001) 162-171
12. Szokodi I., Tavi P., Foldes G., et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91 (2002) 434-440
13. Salcedo A., Garijo J., Monge L., et al. Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids. Regul Pept 144 (2007) 50-55
14. Gurzu B., Petrescu B.C., Costuleanu M., et al. Interactions between apelin and angiotensin II on rat portal vein. J Renin Angiotensin Aldosterone Syst 7 (2006) 212-216
15. Kleinz M.J., and Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 107 (2005) 198-211
16. Dai T., Ramirez-Correa G., and Gao W.D. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553 1-3 (2006) 222-228
17. Zhong J.C., Yu X.Y., Huang Y., et al. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 74 (2007) 388-395
18. Andersen C.U., Mulvany M.J., and Simonsen U. Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats. Eur J Pharmacol 510 (2005) 87-96
19. Sheikh A.Y., Chun H.J., Glassford A.J., et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 294 (2008) H88-H98
20. Eyries M., Siegfried G., Ciumas M., et al. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 103 (2008) 432-440
21. Ostergaard L., Stankevicius E., Andersen M.R., et al. Diminished NO release in chronic hypoxic human endothelial cells. Am J Physiol Heart Circ Physiol 293 5 (2007) H2894-H2903
22. Uzun O., Balbay O., Comunoglu N.U., et al. Hypobaric-hypoxia-induced pulmonary damage in rats ameliorated by antioxidant erdosteine. Acta Histochem 108 (2006) 59-68
23. Atluri P., Morine K.J., Liao G.P., et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 12 (2007) 127-138
24. Iwanaga Y., Kihara Y., Takenaka H., et al. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 41 (2006) 798-806
25. Chen M.M., Ashley E.A., Deng D.X., et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 (2003) 1432-1439
26. Foldes G., Horkay F., Szokodi I., et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 308 (2003) 480-485
27. Glassford A.J., Yue P., Sheikh A.Y., et al. HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 293 (2007) E1590-E1596
28. Bai B., Liu Y.H., and Liu H.Q. Effect of nitric oxide on the expression of apelin receptor mRNA in rat caudate nucleus. Neurosci Bull 23 (2007) 180-184
29. Kleinz M.J., Skepper J.N., and Davenport A.P. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126 (2005) 233-240
30. Japp A.G., and Newby D.E. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 75 (2008) 1882-1892